{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:52:47Z","timestamp":1786737167710,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Ann"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ua.ua_152_19","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T12:59:56Z","timestamp":1602766796000},"page":"301","source":"Crossref","is-referenced-by-count":12,"title":["Applications of electromotive drug administration in urology"],"prefix":"10.4103","volume":"12","author":[{"given":"Sachin","family":"Malde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiya","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7796.298180-1","first-page":"1183","volume-title":"New frontiers in intravesical therapies and drug delivery","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"key-10.4103\/0974-7796.298180-2","unstructured":"CADTH Rapid Response Reports. In: The Use of the Electromotive Drug Administration System in Patients with Overactive Bladder: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014,"},{"key":"key-10.4103\/0974-7796.298180-3","first-page":"285","volume-title":"The future of intravesical drug delivery for non-muscle invasive bladder cancer","author":"Douglass","year":"2016","journal-title":"Bladder Cancer"},{"key":"key-10.4103\/0974-7796.298180-4","first-page":"415","volume-title":"The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer","author":"Slater","year":"2014","journal-title":"Ann R Coll Surg Engl"},{"key":"key-10.4103\/0974-7796.298180-5","first-page":"365","volume-title":"Iontophoretic delivery of model inorganic and drug ions","author":"Phipps","year":"1989","journal-title":"J Pharm Sci"},{"key":"key-10.4103\/0974-7796.298180-6","first-page":"1851","volume-title":"Intravesical electromotive drug administration technique: Preliminary results and side effects","author":"Riedl","year":"1998","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-7","first-page":"506","volume-title":"Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: A comparative Phase II study","author":"Brausi","year":"1998","journal-title":"Urology"},{"key":"key-10.4103\/0974-7796.298180-8","first-page":"777","volume-title":"Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: A prospective randomized study","author":"Di","year":"2003","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-9","first-page":"CD011864","volume-title":"Intravesical electromotive drug administration for non-muscle invasive bladder cancer","author":"Jung","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-7796.298180-10","first-page":"1224","volume-title":"ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk \u201cBCG failure\u201d non muscle invasive bladder cancer: 3 years follow-up outcomes","author":"Racioppi","year":"2018","journal-title":"BMC Cancer"},{"key":"key-10.4103\/0974-7796.298180-11","first-page":"43","volume-title":"Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial","author":"Di","year":"2006","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0974-7796.298180-12","first-page":"1697","volume-title":"Sequential bacillus calmette-gu\u00e9rin\/electromotive drug administration of mitomycin C as the standard intravesical regimen in high risk nonmuscle invasive bladder cancer: 2-year outcomes","author":"Gan","year":"2016","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-13","first-page":"95","volume-title":"Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication.a pilot study on marker lesion","author":"Colombo","year":"2001","journal-title":"Eur Urol"},{"key":"key-10.4103\/0974-7796.298180-14","first-page":"871","volume-title":"Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: A randomised controlled trial","author":"Di","year":"2011","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0974-7796.298180-15","first-page":"209","volume-title":"Electromotive drug-administration: A pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity","author":"Bach","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"key-10.4103\/0974-7796.298180-16","first-page":"758","volume-title":"Electromotive drug administration for treatment of therapy-refractory overactive bladder","author":"Gauruder-Burmester","year":"2008","journal-title":"Int Braz J Urol"},{"key":"key-10.4103\/0974-7796.298180-17","first-page":"439","volume-title":"Intravesical electromotive botulinum toxin type A administration--part II: Clinical application","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"key-10.4103\/0974-7796.298180-18","first-page":"167","volume-title":"Intravesical electromotive botulinum toxin type \u201cA\u201d administration for management of urinary incontinence secondary to neuropathic detrusor overactivity in children: Long-term follow-up","author":"Ladi-Seyedian","year":"2018","journal-title":"Urology"},{"key":"key-10.4103\/0974-7796.298180-19","doi-asserted-by":"crossref","unstructured":"Koh C, Melling CV, Jennings C, Lewis M, Goyal A. Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity-outcomes of a pilot study. J Pediatr Urol 2019;15:552.e1.","DOI":"10.1016\/j.jpurol.2019.05.028"},{"key":"key-10.4103\/0974-7796.298180-20","first-page":"491","volume-title":"Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens","author":"Di","year":"2001","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-21","first-page":"269","volume-title":"Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis","author":"Riedl","year":"1998","journal-title":"J Endourol"},{"key":"key-10.4103\/0974-7796.298180-22","first-page":"134","volume-title":"Intravesical electromotive drug administration for the treatment of non-infectious chronic cystitis","author":"Riedl","year":"1997","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"key-10.4103\/0974-7796.298180-23","first-page":"354","volume-title":"Instillation of hyaluronic acid via electromotive drug administration can improve the efficacy of treatment in patients with interstitial cystitis\/painful bladder syndrome: A randomized prospective study","author":"G\u00fclp\u0131nar","year":"2014","journal-title":"Korean J Urol"},{"key":"key-10.4103\/0974-7796.298180-24","first-page":"443","volume-title":"Electromotive administration of intravesical lidocaine in patients with interstitial cystitis","author":"Gurpinar","year":"1996","journal-title":"J Endourol"},{"key":"key-10.4103\/0974-7796.298180-25","first-page":"142","volume-title":"Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis","author":"Rosamilia","year":"1997","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"key-10.4103\/0974-7796.298180-26","first-page":"2108","volume-title":"Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: Introduction of a new test","author":"Riedl","year":"2000","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-27","first-page":"482","volume-title":"Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery","author":"Jewett","year":"1999","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-28","first-page":"370","volume-title":"The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis\/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain","author":"Parsons","year":"2011","journal-title":"BJU Int"},{"key":"key-10.4103\/0974-7796.298180-29","first-page":"1496","volume-title":"Electromotive drug administration to the urinary bladder: An animal model and preliminary results","author":"G\u00fcrpinar","year":"1996","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.298180-30","first-page":"1460","volume-title":"Intravesical electromotive botulinum toxin type A administration: Part I--Experimental study","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"key-10.4103\/0974-7796.298180-31","first-page":"1117","volume-title":"Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: A single-center study","author":"Kuo","year":"2014","journal-title":"Eur Urol"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:01Z","timestamp":1786733461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/UA.UA_152_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["298180"],"URL":"https:\/\/doi.org\/10.4103\/ua.ua_152_19","relation":{},"ISSN":["0974-7796"],"issn-type":[{"value":"0974-7796","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}